COPD
Conditions
Interventions
Treatment group:Chinese medicine granules
Control group:Placebo
Sponsors
Zhejiang Provincial Hospital of TCM
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. consistent with chronic obstructive pulmonary disease diagnosis, staging is stable; 2. between the age of 40-80 years; 3. voluntary test and signed informed consent, informed consent process ethical requirements. Patients participating in drug research, is supposed to be grouped in the B-D group, in line with the lung and spleen qi deficiency syndromes or lung and kidney qi-and-Yin deficiency syndromes.
Exclusion criteria
Exclusion criteria: 1.combined heart, liver, kidney, brain, hematopoietic system and other more serious primary disease; 2.combined with tumor, hyperthyroidism, diabetes, peptic ulcer and other diseases; 3.pregnant or lactating women; 4.psychiatric patients; 5.extremity disease in lower limb that affects walking function; 6.who are participating in other clinical trials; 7.unwilling to accept the study measures, or some other reason that can not cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung function;Chest X-ray or CT;CAT score;TCM symptom score;BODE score; | — |
Countries
China
Contacts
Public ContactWang Zhen
Zhejiang Provincial Hospital of TCM
Outcome results
None listed